Formulation of stimuli-responsive gels containing silver complex with nicotinamide
, , , , y
31 ago 2025
Acerca de este artículo
Categoría del artículo: Research paper
Publicado en línea: 31 ago 2025
Recibido: 09 jun 2025
Aceptado: 08 jul 2025
DOI: https://doi.org/10.2478/afpuc-2025-0007
Palabras clave
© 2025 Wolaschka Tomáš et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1.

Figure 2.

Figure 3.

Figure 4.

Appearance and injectability of sols and gels_
PMSA 0.2 | +++ | − | + | ++ | ++ | +++ |
PMSA 0.3 | +++ | − | + | + | ++ | +++ |
PMSA 0.4 | +++ | +++ | + | + | + | +++ |
PMSA 0.5 | +++ | +++ | + | + | + | +++ |
PMSA 0.6 | +++ | +++ | + | + | + | ++ |
PMSA 0.7 | ++ | ++ | + | + | + | ++ |
PMSA 0.8 | ++ | ++ | + | + | + | ++ |
PSA | +++ | − | − | − | + | + |
PMSA | +++ | − | − | − | + | + |
MSA | ++ | − | − | + | + | + |
SA | ++ | − | − | + | + | + |
PMSA AgNam | + | − | − | − | + | + |
pH and critical sol–gel transition temperature of the formulations_
PMSA 0.2 | 6.78 ± 0.00 | - |
PMSA 0.3 | 6.72 ± 0.00 | - |
PMSA 0.4 | 6.70 ± 0.00 | 34.10 ± 0.28 |
PMSA 0.5 | 6.68 ± 0.01 | 33.36 ± 0.13 |
PMSA 0.6 | 6.64 ± 0.00 | 32.66 ± 0.17 |
PMSA 0.7 | 6.61 ± 0.00 | 33.60 ± 0.08 |
PMSA 0.8 | 6.60 ± 0.01 | 31.50 ± 0.36 |
PSA | 6.16 ± 0.02 | - |
PMSA | 6.26 ± 0.00 | - |
MSA | 5.84 ± 0.00 | - |
SA | 5.75 ± 0.01 | - |
PMSA AgNAM | 5.61± 0.02 | - |
Composition of formulations_
PMSA 0.2 | 15.00 | 0.25 | 0.20 | - |
PMSA 0.3 | 15.00 | 0.25 | 0.30 | - |
PMSA 0.4 | 15.00 | 0.25 | 0.40 | - |
PMSA 0.5 | 15.00 | 0.25 | 0.50 | - |
PMSA 0.6 | 15.00 | 0.25 | 0.60 | - |
PMSA 0.7 | 15.00 | 0.25 | 0.70 | - |
PMSA 0.8 | 15.00 | 0.25 | 0.80 | - |
PSA | 15.00 | - | 4.00 | - |
PMSA | 15.00 | 0.25 | 4.00 | - |
MSA | - | 0.25 | 4.00 | - |
SA | - | - | 4.00 | - |
PMSA AgNam | 15.00 | 0.25 | 4.00 | 1.00 |